<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Short QT syndrome was first described in 2000 </plain></SENT>
<SENT sid="1" pm="."><plain>It is a <z:hpo ids='HP_0003745'>sporadic</z:hpo> or familial ion channel disease that is associated with abbreviation of the QT interval permanently or transiently </plain></SENT>
<SENT sid="2" pm="."><plain>The time of first manifestation of symptoms such as <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> or <z:hpo ids='HP_0001279'>syncope</z:hpo> or even <z:hpo ids='HP_0001699'>sudden death</z:hpo> is between the 2nd and 4th decade </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001699'>Sudden death</z:hpo> has also been described for newborns and adolescents </plain></SENT>
<SENT sid="4" pm="."><plain>Therapy depends on the severity of the symptoms </plain></SENT>
<SENT sid="5" pm="."><plain>The therapy of choice for secondary prevention of <z:hpo ids='HP_0001699'>sudden death</z:hpo> is the implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="28593">Quinidine</z:chebi> has been shown to be effective in preventing <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in a number of patients </plain></SENT>
<SENT sid="7" pm="."><plain>It is mostly used as an adjunct to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> but has also been used with considerable success in children and individuals who refused <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation </plain></SENT>
</text></document>